RET Gene Mutations in a Chinese Family with MEN 2A/FMTC
Author Information
Author(s): Qi Xiao-Ping, Ma Ju-Ming, Du Zhen-Fang, Ying Rong-Biao, Fei Jun, Jin Hang-Yang, Han Jian-Shan, Wang Jin-Quan, Chen Xiao-Ling, Chen Chun-Yue, Liu Wen-Ting, Lu Jia-Jun, Zhang Jian-Guo, Zhang Xian-Ning
Primary Institution: The 117th PLA Hospital, Zhejiang University
Hypothesis
Can whole exome sequencing effectively identify RET mutations in a family with multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma?
Conclusion
Whole exome sequencing successfully identified RET mutations, indicating that certain mutations may lead to more aggressive clinical phenotypes.
Supporting Evidence
- Four missense mutations of the RET gene were identified.
- The proband's daughter presented a novel compound mutation.
- Clinical follow-up showed varying degrees of disease severity among family members.
- Whole exome sequencing provided a direct method for genetic diagnosis.
Takeaway
Scientists looked at the genes of a family with a type of thyroid cancer and found some changes that could make the cancer worse.
Methodology
Whole exome sequencing was performed on six individuals from a Chinese family to identify RET mutations, followed by clinical evaluations and surgical interventions.
Limitations
The study focused on a small family, which may limit the generalizability of the findings.
Participant Demographics
The study involved a Chinese family with multiple generations affected by MEN 2A/FMTC.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website